Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from IP Group plc ( (GB:IPO) ).
IP Group plc, a UK-listed early-stage science and technology investor, concentrates on healthtech, deeptech and cleantech, primarily funding innovation spun out of universities and research institutions. Through its specialist investment teams and vehicles such as Parkwalk, the Group has built a portfolio of prominent growth companies and positions itself as a key conduit for commercialising breakthrough research.
The Group has appointed former 3i Group chief executive Michael Queen as non-executive director and chair designate, completing a chair succession that will see him succeed Sir Douglas Flint after the June 2026 AGM. Queen’s background in scaling institutional capital platforms and his experience in private markets, infrastructure and the university sector are expected to bolster IP Group’s strategy to grow funds under management, refresh its portfolio and drive long-term value creation for stakeholders.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £110.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
Spark’s Take on IPO Stock
According to Spark, TipRanks’ AI Analyst, IPO is a Neutral.
The score is held back primarily by volatile operating performance and weak, inconsistent cash generation despite a 2025 profitability rebound. This is partially offset by a resilient balance sheet, constructive price momentum above key moving averages, and a relatively low P/E valuation.
To see Spark’s full report on IPO stock, click here.
More about IP Group plc
IP Group plc is a UK-based investment company focused on early-stage science and technology ventures, with a particular emphasis on healthtech, deeptech and cleantech. Listed on the London Stock Exchange, it backs innovation emerging from leading universities and research institutions, including via Parkwalk, the UK’s largest growth EIS fund manager, and has supported high-profile firms such as Oxford Nanopore Technologies and Hinge Health.
Average Trading Volume: 3,502,609
Technical Sentiment Signal: Buy
Current Market Cap: £546.8M
For a thorough assessment of IPO stock, go to TipRanks’ Stock Analysis page.